Literature DB >> 23683308

Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort.

David M Mannino1, Kourtney J Davis, Rachael L Disantostefano.   

Abstract

BACKGROUND AND
OBJECTIVE: We sought to determine the relationship between chronic respiratory disease, cardiovascular disease (CVD) and mortality in a nationally representative cohort of the US population aged 40 years and older.
METHODS: We analysed data from the baseline (1988-1994) and follow-up of the Third National Health and Nutrition Examination Survey (NHANES III). Subjects were classified in to one of four categories: obstructed (forced expiratory volume in 1 s/forced vital capacity <70% and forced expiratory volume in 1 s <80% predicted), restricted (forced expiratory volume in 1 s/forced vital capacity ≥70% and forced vital capacity <80% predicted), symptomatic (neither obstructed nor restricted but reporting respiratory symptoms) and normal (none of the above). Subjects were classified as having overt CVD, CVD risk factors only or neither at the baseline examination.
RESULTS: The analysis data set included 9054 subjects, of whom 1132 (12.0%, weighted percentage (WP)) were obstructed, 1319 (10.3%, WP) were restricted and 2457 were symptomatic (27.6%, WP). Overt CVD was present at baseline in 1284 subjects (10.4 %, WP), and CVD risk factors alone were present in 4900 (53.3%, WP). Three thousand five hundred seventy-one (28.4%, WP) subjects died during the up to 18-year follow-up period. When compared with 'normal' subjects, those in the obstructed group were more likely to have overt CVD (odds ratio 1.87, 95% confidence interval: 1.15-3.04, P < 0.001), with a similar risk seen in the restricted and symptomatic group.
CONCLUSIONS: In this large US population-based cohort, the presence of obstruction, restriction or respiratory symptoms alone was associated with higher adjusted risk of overt CVD.
© 2013 The Authors. Respirology © 2013 Asian Pacific Society of Respirology.

Entities:  

Keywords:  cardiovascular disease; mortality; obstruction; restriction; spirometry

Mesh:

Year:  2013        PMID: 23683308     DOI: 10.1111/resp.12119

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  3 in total

1.  Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort.

Authors:  Yewande E Odeyemi; O'Dene Lewis; Julius Ngwa; Kristen Dodd; Richard F Gillum; Alem Mehari
Journal:  J Natl Med Assoc       Date:  2018-07-29       Impact factor: 1.798

2.  Determining urea levels in exhaled breath condensate with minimal preparation steps and classic LC-MS.

Authors:  Masha Pitiranggon; Matthew S Perzanowski; Patrick L Kinney; Dongqun Xu; Steven N Chillrud; Beizhan Yan
Journal:  J Chromatogr Sci       Date:  2013-11-04       Impact factor: 1.618

3.  Multimorbidity patterns in a national representative sample of the Spanish adult population.

Authors:  Noe Garin; Beatriz Olaya; Jaime Perales; Maria Victoria Moneta; Marta Miret; Jose Luis Ayuso-Mateos; Josep Maria Haro
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.